drugset / Trial / NCT02078817

Ketamine in Adolescents With Treatment-Resistant Depression

NCT02078817 ↗

Phase 2 Completed 14 enrolled University of Minnesota
NaSingle-groupOpen-labelTreatment

Summary

This study will test the use of ketamine for treatment of depression in adolescents that have not responded to other treatments. We will also examine neurobiological mechanisms of treatment.

Timeline

Start
2014-09
Primary completion
2018-03
Completion
2018-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.5 mg/kg Intravenous